Microarray patch (MAP) technologies can address the need for improved presentations of vaccines and pharmaceuticals. The PATH Center of Excellence for MAP Technology is working to advance MAP development for high priority needs in low- and middle-income countries (LMICs). A key element of this work is evaluating global health use cases and understanding potential usability, acceptability, and programmatic fit of MAPs for specific applications and use cases, including rabies, HPV, and outbreak response.

This report describes the user and program needs activities that have been conducted as part of the MAP Center of Excellence and includes a high-level summary of the results for different applications and lessons learned that are relevant for the MAP platform as a whole.